Related Experiment Video
Updated: Feb 27, 2026

08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
8.3K
Efficient Receptor Mediated siRNA Delivery in Vitro by Folic Acid Targeted Pentablock Copolymer-Based Micelleplexes
Roman Lehner1, Kegang Liu1, Xueya Wang1
1Nanomedicine Research Lab CLINAM, University Hospital Basel, University of Basel , Bernoullistrasse 20, Basel CH-4056, Switzerland.
Biomacromolecules
|July 6, 2017
Summary
Researchers developed novel biocompatible polyplexes for targeted siRNA delivery. These stable nanocarriers show potential for RNA inhibition therapies by effectively delivering siRNA to specific cells, minimizing off-target effects.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Gene Therapy
Background:
- Developing effective and safe delivery systems for small interfering RNA (siRNA) is crucial for RNA interference (RNAi) therapies.
- Polymeric nanoparticles offer potential for nucleic acid delivery but often face challenges with stability and non-specific interactions.
Purpose of the Study:
- To design and develop novel, biocompatible polyplexes for target-specific siRNA delivery.
- To evaluate the stability, targeting efficiency, and gene silencing capability of the developed nanocarriers.
Main Methods:
- Synthesis of cationic pentablock copolymers and folic acid functionalized copolymers.
- Formation of micelleplexes with a hydrophobic core and shielded cationic/hydrophilic layers.
- Assessment of particle stability in serum and gene knockdown efficacy in GFP-expressing HeLa cells.
- Investigation of cellular uptake mechanisms using receptor-mediated endocytosis in HeLa and HEK293 cells.
Main Results:
- The developed micelleplexes demonstrated high stability in complete serum over 24 hours, outperforming polyethyleneimine (PEI).
- Targeted siRNA delivery resulted in approximately 31% suppression of GFP expression in HeLa cells, compared to 8% for non-targeted micelleplexes.
- Receptor-mediated cellular uptake was confirmed through comparative studies using folic-receptor positive HeLa cells and negative HEK293 cells.
- The nanocarrier exhibited no cytotoxicity.
Conclusions:
- The novel polyplexes provide a stable and biocompatible platform for targeted siRNA delivery.
- The combination of a stealth shielding layer and folic acid targeting moiety effectively overcomes common challenges in polymeric nucleic acid delivery systems.
- This approach holds significant potential for in vivo RNA inhibition applications, minimizing undesired protein and cell interactions.

